INSIDER · CIK 1410514
Kelly Thomas Patrick
Chief Financial Officer at Xenon Pharmaceuticals Inc. (XENE)
↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$560KBought on the market
$0.00Sold on the market
1Companies
Oct 16, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 202620:22 | Oct 15, 2026 | XENEXenon Pharmaceuticals Inc. | Chief Financial Officer | M · Exercise | — | +7,500 | 22,500 | +50% | — | ||
| Oct 1, 202609:20 | Sep 30, 2026 | XENEXenon Pharmaceuticals Inc. | Chief Financial Officer | P · Buy | $37.32 | +15,000 | 15,000 | New | +$560K | -47.4% | +0.6% |